1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope
2. Executive Summary
2.1. Market Snapshot: Global Rare Inflammatory Disease Treatment Market
2.2. Global Rare Inflammatory Disease Treatment Market, By Indication
2.3. Global Rare Inflammatory Disease Treatment Market, By Drug Class
2.4. Global Rare Inflammatory Disease Treatment Market, By Mode of Administration
2.5. Global Rare Inflammatory Disease Treatment Market, By Distribution Channel
2.6. Global Rare Inflammatory Disease Treatment Market, By Region
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Rare Inflammatory Disease Treatment Market Value, 2017-2030, (US$ Mn))
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type
3.5.2. Drug Class
3.5.3. Mode of Administration
3.5.4. Distribution Channel
3.5.5. Geography
4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Indication Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. InDirect Marketing
4.7.3. Marketing Channel Development Trend
5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others
6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa
7. Global Rare Inflammatory Disease Treatment Market
7.1. Global Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
7.1.1. Overview
7.1.2. Global Rare Inflammatory Disease Treatment Market, By Indication, 2022 vs 2030 (in%)
7.1.3. Global Rare Inflammatory Disease Treatment Market, By Ulcerative Colitis, 2017-2030 (US$ Mn))
7.1.4. Global Rare Inflammatory Disease Treatment Market, By Juvenile Rheumatoid Arthritis, 2017-2030 (US$ Mn))
7.1.5. Global Rare Inflammatory Disease Treatment Market, By Psoriatic Arthritis, 2017-2030 (US$ Mn))
7.1.6. Global Rare Inflammatory Disease Treatment Market, By Others, 2017-2030 (US$ Mn))
7.2. Global Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
7.2.1. Overview
7.2.2. Global Rare Inflammatory Disease Treatment Market, By Drug Class, 2022 vs 2030 (in%)
7.2.3. Global Rare Inflammatory Disease Treatment Market, By Biologics, 2017-2030 (US$ Mn))
7.2.4. Global Rare Inflammatory Disease Treatment Market, By Organic Compounds, 2017-2030 (US$ Mn))
7.3. Global Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
7.3.1. Overview
7.3.2. Global Rare Inflammatory Disease Treatment Market, By Mode of Administration, 2022 vs 2030 (in%)
7.3.3. Global Rare Inflammatory Disease Treatment Market, By Injectables, 2017-2030 (US$ Mn))
7.3.4. Global Rare Inflammatory Disease Treatment Market, By Oral, 2017-2030 (US$ Mn))
7.3.5. Global Rare Inflammatory Disease Treatment Market, By Others, 2017-2030 (US$ Mn))
7.4. Global Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
7.4.1. Overview
7.4.2. Global Rare Inflammatory Disease Treatment Market, By Distribution Channel, 2022 vs 2030 (in%)
7.4.3. Global Rare Inflammatory Disease Treatment Market, By Hospital Pharmacies, 2017-2030 (US$ Mn))
7.4.4. Global Rare Inflammatory Disease Treatment Market, By Retail Pharmacies, 2017-2030 (US$ Mn))
8. North America Rare Inflammatory Disease Treatment Market Analysis
8.1. North America Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030(US$ Mn))
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030(US$ Mn))
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030(US$ Mn))
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030(US$ Mn))
8.4.1. Overview
8.4.2. SRC Analysis
8.5. North America Rare Inflammatory Disease Treatment Market, by Country, 2017-2030 (US$ Mn))
8.5.1. U.S.
8.5.1.1. U.S. Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
8.5.1.2. U.S. Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
8.5.1.3. U.S. Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
8.5.1.4. U.S. Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
8.5.1.5. U.S. Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
8.5.2. Canada
8.5.2.1. Canada Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
8.5.2.2. Canada Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
8.5.2.3. Canada Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
8.5.2.4. Canada Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
8.5.2.5. Canada Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
9. Europe Rare Inflammatory Disease Treatment Market Analysis
9.1. Europe Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030(US$ Mn))
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030(US$ Mn))
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030(US$ Mn))
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030(US$ Mn))
9.4.1. Overview
9.4.2. SRC Analysis
9.5. Europe Rare Inflammatory Disease Treatment Market, by Country, 2017-2030 (US$ Mn))
9.5.1. Germany
9.5.1.1. Germany Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.5.1.2. Germany Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
9.5.1.3. Germany Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
9.5.1.4. Germany Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
9.5.1.5. Germany Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
9.5.2. France
9.5.2.1. France Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.5.2.2. France Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
9.5.2.3. France Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
9.5.2.4. France Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
9.5.2.5. France Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
9.5.3. UK
9.5.3.1. UK Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.5.3.2. UK Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
9.5.3.3. UK Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
9.5.3.4. UK Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
9.5.3.5. UK Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
9.5.4. Italy
9.5.4.1. Italy Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.5.4.2. Italy Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
9.5.4.3. Italy Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
9.5.4.4. Italy Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
9.5.4.5. Italy Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
9.5.5. Spain
9.5.5.1. Spain Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.5.5.2. Spain Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
9.5.5.3. Spain Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
9.5.5.4. Spain Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
9.5.5.5. Spain Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
9.5.6. Rest of Europe
9.5.6.1. Rest of Europe Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.5.6.2. Rest of Europe Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
9.5.6.3. Rest of Europe Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
9.5.6.4. Rest of Europe Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
9.5.6.5. Rest of Europe Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
10. Asia Pacific Rare Inflammatory Disease Treatment Market Analysis
10.1. Asia Pacific Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030(US$ Mn))
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030(US$ Mn))
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030(US$ Mn))
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030(US$ Mn))
10.4.1. Overview
10.4.2. SRC Analysis
10.5. Asia Pacific Rare Inflammatory Disease Treatment Market, by Country, 2017-2030 (US$ Mn))
10.5.1. China
10.5.1.1. China Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.5.1.2. China Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
10.5.1.3. China Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
10.5.1.4. China Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
10.5.1.5. China Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
10.5.2. Japan
10.5.2.1. Japan Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.5.2.2. Japan Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
10.5.2.3. Japan Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
10.5.2.4. Japan Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
10.5.2.5. Japan Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
10.5.3. India
10.5.3.1. India Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.5.3.2. India Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
10.5.3.3. India Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
10.5.3.4. India Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
10.5.3.5. India Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
10.5.4. South Korea
10.5.4.1. South Korea Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.5.4.2. South Korea Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
10.5.4.3. South Korea Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
10.5.4.4. South Korea Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
10.5.4.5. South Korea Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
10.5.5. South-East Asia
10.5.5.1. South-East Asia Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.5.5.2. South-East Asia Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
10.5.5.3. South-East Asia Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
10.5.5.4. South-East Asia Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
10.5.5.5. South-East Asia Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
10.5.6. Rest of Asia Pacific
10.5.6.1. Rest of Asia Pacific Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.5.6.2. Rest of Asia Pacific Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
10.5.6.3. Rest of Asia Pacific Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
10.5.6.4. Rest of Asia Pacific Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
10.5.6.5. Rest of Asia Pacific Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
11. Latin America Rare Inflammatory Disease Treatment Market Analysis
11.1. Latin America Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030(US$ Mn))
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030(US$ Mn))
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030(US$ Mn))
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030(US$ Mn))
11.4.1. Overview
11.4.2. SRC Analysis
11.5. Latin America Rare Inflammatory Disease Treatment Market, by Country, 2017-2030 (US$ Mn))
11.5.1. Brazil
11.5.1.1. Brazil Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
11.5.1.2. Brazil Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
11.5.1.3. Brazil Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
11.5.1.4. Brazil Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
11.5.1.5. Brazil Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
11.5.2. Mexico
11.5.2.1. Mexico Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
11.5.2.2. Mexico Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
11.5.2.3. Mexico Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
11.5.2.4. Mexico Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
11.5.2.5. Mexico Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
11.5.3. Rest of Latin America
11.5.3.1. Rest of Latin America Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
11.5.3.2. Rest of Latin America Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
11.5.3.3. Rest of Latin America Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
11.5.3.4. Rest of Latin America Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
11.5.3.5. Rest of Latin America Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
12. Middle East and Africa Rare Inflammatory Disease Treatment Market Analysis
12.1. Middle East and Africa Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030(US$ Mn))
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030(US$ Mn))
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030(US$ Mn))
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030(US$ Mn))
12.4.1. Overview
12.4.2. SRC Analysis
12.5. Middle East and Africa Rare Inflammatory Disease Treatment Market, by Country, 2017-2030 (US$ Mn))
12.5.1. GCC Countries
12.5.1.1. GCC Countries Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
12.5.1.2. GCC Countries Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
12.5.1.3. GCC Countries Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
12.5.1.4. GCC Countries Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
12.5.1.5. GCC Countries Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
12.5.2. South Africa
12.5.2.1. South Africa Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
12.5.2.2. South Africa Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
12.5.2.3. South Africa Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
12.5.2.4. South Africa Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
12.5.2.5. South Africa Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
12.5.3. Rest of Middle East and Africa
12.5.3.1. Rest of Middle East and Africa Rare Inflammatory Disease Treatment Market Estimates and Forecast, 2017-2030 (US$ Mn))
12.5.3.2. Rest of Middle East and Africa Rare Inflammatory Disease Treatment, By Indication, 2017-2030 (US$ Mn))
12.5.3.3. Rest of Middle East and Africa Rare Inflammatory Disease Treatment, By Drug Class, 2017-2030 (US$ Mn))
12.5.3.4. Rest of Middle East and Africa Rare Inflammatory Disease Treatment, By Mode of Administration, 2017-2030 (US$ Mn))
12.5.3.5. Rest of Middle East and Africa Rare Inflammatory Disease Treatment, By Distribution Channel, 2017-2030 (US$ Mn))
13. Company Profiles
13.1. Pfizer Inc.
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2022)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Bausch Health Companies Inc
13.3. Novartis AG
13.4. Allergan Plc
13.5. Abbott
13.6. Regeneron Pharmaceuticals, Inc
13.7. Abbvie, Inc
13.8. Mallinckrodt
13.9. Celtaxsys
13.10. CSL
List of Figures
FIG. 1 Global Rare Inflammatory Disease Treatment Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Rare Inflammatory Disease Treatment Market Segmentation
FIG. 4 Global Rare Inflammatory Disease Treatment Market, by Indication, 2022 (US$ Mn))
FIG. 5 Global Rare Inflammatory Disease Treatment Market, by Drug Class, 2022 (US$ Mn))
FIG. 6 Global Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2022 (US$ Mn))
FIG. 7 Global Rare Inflammatory Disease Treatment Market, by Geography, 2022 (US$ Mn))
FIG. 8 Attractive Investment Proposition, by Indication, 2022
FIG. 9 Attractive Investment Proposition, by Drug Class, 2022
FIG. 10 Attractive Investment Proposition, by Distribution Channel, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Rare Inflammatory Disease Treatment Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Rare Inflammatory Disease Treatment Market Manufacturers, 2022
FIG. 14 Global Rare Inflammatory Disease Treatment Market Value Contribution, By Indication, 2022 & 2030 (Value %)
FIG. 15 Global Rare Inflammatory Disease Treatment Market, by Ulcerative Colitis, Value, 2017-2030 (US$ Mn))
FIG. 16 Global Rare Inflammatory Disease Treatment Market, by Juvenile Rheumatoid Arthritis, Value, 2017-2030 (US$ Mn))
FIG. 17 Global Rare Inflammatory Disease Treatment Market, by Psoriatic Arthritis, Value, 2017-2030 (US$ Mn))
FIG. 18 Global Rare Inflammatory Disease Treatment Market, by Others, Value, 2017-2030 (US$ Mn))
FIG. 19 Global Rare Inflammatory Disease Treatment Market Value Contribution, By Drug Class, 2022 & 2030 (Value %)
FIG. 20 Global Rare Inflammatory Disease Treatment Market, by Biologics, Value, 2017-2030 (US$ Mn))
FIG. 21 Global Rare Inflammatory Disease Treatment Market, by Organic Compounds, 2017-2030 (US$ Mn))
FIG. 22 Global Rare Inflammatory Disease Treatment Market Value Contribution, By Distribution Channel, 2022 & 2030 (Value %)
FIG. 23 Global Rare Inflammatory Disease Treatment Market, by Hospital Pharmacies, Value, 2017-2030 (US$ Mn))
FIG. 24 Global Rare Inflammatory Disease Treatment Market, by Retail Pharmacies, 2017-2030 (US$ Mn))
FIG. 25 North America Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 26 U.S. Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 27 Canada Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 28 Europe Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 29 Germany Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 30 France Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 31 U.K. Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 32 Italy Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 33 Spain Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 34 Rest of Europe Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 35 Asia Pacific Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 36 China Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 37 Japan Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 38 India Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 39 South Korea Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 40 South-East Asia Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 41 Rest of Asia Pacific Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 42 Latin America Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 43 Brazil Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 44 Mexico Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 45 Rest of Latin America Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 46 Middle East & Africa Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 47 GCC Countries Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 48 South Africa Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
FIG. 49 Rest of Middle East and Africa Rare Inflammatory Disease Treatment Market, 2017-2030 (US$ Mn))
List of Tables
TABLE 1 Market Snapshot: Global Rare Inflammatory Disease Treatment Market
TABLE 2 Global Rare Inflammatory Disease Treatment Market, by Competitive Benchmarking, 2022
TABLE 3 Global Rare Inflammatory Disease Treatment Market, by Geographical Presence Analysis, 2022
TABLE 4 Global Rare Inflammatory Disease Treatment Market, by Key Strategies Analysis, 2022
TABLE 5 Global Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 6 Global Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 7 Global Rare Inflammatory Disease Treatment Market, by Mode of Administration,, 2017-2030 (US$ Mn))
TABLE 8 Global Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 9 Global Rare Inflammatory Disease Treatment Market, by Geography, 2017-2030 (US$ Mn))
TABLE 10 North America Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 11 North America Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 12 North America Rare Inflammatory Disease Treatment Market, by Mode of Administration,, 2017-2030 (US$ Mn))
TABLE 13 North America Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 14 North America Rare Inflammatory Disease Treatment Market, by Country, 2017-2030 (US$ Mn))
TABLE 15 US Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 16 US Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 17 US Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 18 US Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 19 Canada Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 20 Canada Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 21 Canada Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 22 Canada Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 23 Europe Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 24 Europe Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 25 Europe Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 26 Europe Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 27 Europe Rare Inflammatory Disease Treatment Market, by Country, 2017-2030 (US$ Mn))
TABLE 28 Germany Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 29 Germany Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 30 Germany Rare Inflammatory Disease Treatment Market, by Mode of Administration,, 2017-2030 (US$ Mn))
TABLE 31 Germany Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 32 France Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 33 France Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 34 France Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 35 France Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 36 UK Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 37 UK Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 38 UK Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 39 UK Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 40 Italy Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 41 Italy Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 42 Italy Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 43 Italy Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 44 Spain Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 45 Spain Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 46 Spain Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 47 Spain Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 48 Rest of Europe Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 49 Rest of Europe Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 50 Rest of Europe Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 51 Rest of Europe Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 52 Asia Pacific Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 53 Asia Pacific Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 54 Asia Pacific Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 55 Asia Pacific Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 56 Asia Pacific Rare Inflammatory Disease Treatment Market, by Country, 2017-2030 (US$ Mn))
TABLE 57 China Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 58 China Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 59 China Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 60 China Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 61 Japan Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 62 Japan Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 63 Japan Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 64 Japan Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 65 India Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 66 India Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 67 India Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 68 India Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 69 South Korea Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 70 South Korea Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 71 South Korea Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 72 South Korea Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 73 South-East Asia Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 74 South-East Asia Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 75 South-East Asia Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 76 South-East Asia Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 77 Rest of Asia Pacific Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 78 Rest of Asia Pacific Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 79 Rest of Asia Pacific Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 80 Rest of Asia Pacific Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 81 Latin America Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 82 Latin America Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 83 Latin America Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 84 Latin America Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 85 Latin America Rare Inflammatory Disease Treatment Market, by Country, 2017-2030 (US$ Mn))
TABLE 86 Brazil Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 87 Brazil Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 88 Brazil Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 89 Brazil Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 90 Mexico Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 91 Mexico Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 92 Mexico Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 93 Mexico Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 94 Rest of Latin America Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 95 Rest of Latin America Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 96 Rest of Latin America Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 97 Rest of Latin America Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 98 Middle East and Africa Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 99 Middle East and Africa Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 100 Middle East and Africa Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 101 Middle East and Africa Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 102 Middle East and Africa Rare Inflammatory Disease Treatment Market, by Country, 2017-2030 (US$ Mn))
TABLE 103 GCC Countries Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 104 GCC Countries Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 105 GCC Countries Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 106 GCC Countries Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 107 South Africa Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 108 South Africa Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 109 South Africa Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 110 South Africa Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 111 Rest of Middle East and Africa Rare Inflammatory Disease Treatment Market, by Indication, 2017-2030 (US$ Mn))
TABLE 112 Rest of Middle East and Africa Rare Inflammatory Disease Treatment Market, by Drug Class, 2017-2030 (US$ Mn))
TABLE 113 Rest of Middle East and Africa Rare Inflammatory Disease Treatment Market, by Mode of Administration, 2017-2030 (US$ Mn))
TABLE 114 Rest of Middle East and Africa Rare Inflammatory Disease Treatment Market, by Distribution Channel, 2017-2030 (US$ Mn))